(CTXR) Citius Pharmaceuticals - Performance -91.9% in 12m
CTXR performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-91.91%
#191 in Peer-Group
Rel. Strength
0.86%
#7597 in Stock-Universe
Total Return 12m
-91.92%
#198 in Peer-Group
Total Return 5y
-94.93%
#170 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 9.13 |
| High / Low | USD |
|---|---|
| 52 Week High | 25.50 USD |
| 52 Week Low | 0.68 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 75.20 |
| Buy/Sell Signal +-5 | -2.47 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: CTXR (-91.9%) vs XLV (-6.7%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
0.9% | 131% | 354% | 62.6 | 55.3 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
2.5% | 13.5% | 82% | 19.4 | 14.7 | 1.44 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
-1.93% | -14.5% | 419% | 63.7 | 35.8 | 1.2 | 58.2% | 18.9% |
| NOVN SW Novartis |
-0.79% | 0.39% | 50.8% | 19.5 | 14.7 | 1.44 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-8.02% | 2.74% | 50.2% | 19.1 | 8.73 | 0.38 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
-3.54% | -6.89% | 49.9% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
| SFZN SW Siegfried Holding |
-6.74% | -9.61% | 106% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| UCB BR UCB |
3.73% | 19% | 62.6% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
Performance Comparison: CTXR vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for CTXR
| Total Return (including Dividends) | CTXR | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 54.46% | 0.06% | 4.01% |
| 3 Months | 65.96% | -0.76% | 17.14% |
| 12 Months | -91.92% | -6.69% | 13.46% |
| 5 Years | -94.93% | 44.47% | 112.73% |
| Trend Score (consistency of price movement) | CTXR | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 85.8% | 32.3% | 90.3% |
| 3 Months | 52.8% | -15.4% | 97.5% |
| 12 Months | -94.9% | -78.9% | 46.4% |
| 5 Years | -79.8% | 87.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th98.00 | 54.36% | 48.50% |
| 3 Month | %th83.50 | 67.22% | 41.67% |
| 12 Month | %th1.50 | -91.34% | -92.88% |
| 5 Years | %th14.50 | -96.49% | -97.62% |
FAQs
Does Citius Pharmaceuticals (CTXR) outperform the market?
No,
over the last 12 months CTXR made -91.92%, while its related Sector, the Health Care Sector SPDR (XLV) made -6.69%.
Over the last 3 months CTXR made 65.96%, while XLV made -0.76%.
Performance Comparison CTXR vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
CTXR vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -26.4% | 50.5% | -63.2% | -105% |
| US NASDAQ 100 | QQQ | -26.3% | 50.3% | -65.2% | -105% |
| German DAX 40 | DAX | -26.7% | 53.2% | -75.3% | -122% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -27.6% | 49.9% | -67.7% | -111% |
| Hongkong Hang Seng | HSI | -27.3% | 51.6% | -85.2% | -127% |
| India NIFTY 50 | INDA | -25% | 55.3% | -63.7% | -89% |
| Brasil Bovespa | EWZ | -22.2% | 55.1% | -78.2% | -93% |
CTXR vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -25% | 52.8% | -66.5% | -116% |
| Consumer Discretionary | XLY | -27.3% | 51.1% | -55.5% | -110% |
| Consumer Staples | XLP | -24.3% | 54.6% | -62.3% | -99% |
| Energy | XLE | -29.3% | 50.3% | -55.6% | -94% |
| Financial | XLF | -24.9% | 51.8% | -65.5% | -117% |
| Health Care | XLV | -26.5% | 54.4% | -51.7% | -85% |
| Industrial | XLI | -26.8% | 50% | -69% | -115% |
| Materials | XLB | -27% | 50% | -63.8% | -96% |
| Real Estate | XLRE | -26.1% | 54.6% | -61.7% | -100% |
| Technology | XLK | -26.3% | 47.8% | -68.3% | -103% |
| Utilities | XLU | -26.4% | 51.9% | -67.2% | -112% |
| Aerospace & Defense | XAR | -27% | 47.6% | -83.2% | -141% |
| Biotech | XBI | -30% | 51.3% | -53% | -81% |
| Homebuilder | XHB | -29.4% | 45.7% | -56.6% | -91% |
| Retail | XRT | -26.3% | 51.2% | -58.4% | -98% |
CTXR vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -27% | 51.2% | -49.3% | -87% |
| Natural Gas | UNG | -24.6% | 60.9% | -37.2% | -90% |
| Gold | GLD | -26.5% | 54.2% | -81.1% | -130% |
| Silver | SLV | -30.7% | 48.2% | -85.2% | -114% |
| Copper | CPER | -36.7% | 39.5% | -82.7% | -115% |
CTXR vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -25.5% | 54.5% | -57.9% | -88% |
| iShares High Yield Corp. Bond | HYG | -25.8% | 53.3% | -60.2% | -101% |